CD4 and melanoma: Another recent study by Li et al. [36] aimed to identify the physiological mechanisms by which TIM-3 contained in exosomes from melanoma cells might regulate CD4+ T cell immunological activity and macrophage polarisation in the M2 phenotype in MM.